Difference between revisions of "Part:BBa K404120"

 
(One intermediate revision by one other user not shown)
Line 1: Line 1:
 
__NOTOC__
 
__NOTOC__
 
<partinfo>BBa_K404120 short</partinfo>
 
<partinfo>BBa_K404120 short</partinfo>
 +
<br><br><br>
 +
{| style="color:black" cellpadding="6" cellspacing="1" border="2" align="right"
 +
! colspan="2" style="background:#66bbff;"|[https://parts.igem.org/Part:BBa_K404120 [AAV2]-left-ITR_pCMV_betaglobin_CFP_hGH_[AAV2]-right-ITR ]
 +
|-
 +
! colspan="2"|[[Image:Freiburg10_Vectorplasmid composite 2.png|300px]]
 +
|-
 +
|'''BioBrick Nr.'''
 +
|[https://parts.igem.org/Part:BBa_K404120 BBa_K404120]
 +
|-
 +
|'''RFC standard'''
 +
|[https://parts.igem.org/Help:Assembly_standard_10 RFC 10]<br/>
 +
|-
 +
|'''Requirement'''
 +
|pSB1C3<br>
 +
|-
 +
|'''Source'''
 +
|pAAV_MCS provided by Stratagene
 +
|-
 +
|'''Submitted by'''
 +
|[http://2010.igem.org/Team:Freiburg_Bioware FreiGEM 2010]
 +
|}
 +
<br>
 +
 +
[[Image:Freiburg10_Vectorplasmid composite 2.png|left|thumb|480px]]<br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br>
 +
 +
<html>
 +
<head>
 +
  <meta http-equiv="Content-Type"
 +
content="text/html; charset=windows-1252">
 +
  <meta name="Generator"
 +
content="Microsoft Word 14 (filtered)">
 +
  <style>
 +
<!--
 +
/* Font Definitions */
 +
@font-face
 +
{font-family:Calibri;
 +
panose-1:2 15 5 2 2 2 4 3 2 4;}
 +
/* Style Definitions */
 +
p.MsoNormal, li.MsoNormal, div.MsoNormal
 +
{margin-top:0cm;
 +
margin-right:0cm;
 +
margin-bottom:10.0pt;
 +
margin-left:0cm;
 +
line-height:115%;
 +
font-size:11.0pt;
 +
font-family:"Calibri","sans-serif";}
 +
h1
 +
{mso-style-link:"Heading 1 Char";
 +
margin-top:24.0pt;
 +
margin-right:0cm;
 +
margin-bottom:0cm;
 +
margin-left:0cm;
 +
margin-bottom:.0001pt;
 +
line-height:115%;
 +
page-break-after:avoid;
 +
font-size:14.0pt;
 +
font-family:"Cambria","serif";
 +
color:red;}
 +
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
 +
{margin-top:0cm;
 +
margin-right:0cm;
 +
margin-bottom:10.0pt;
 +
margin-left:36.0pt;
 +
line-height:115%;
 +
font-size:11.0pt;
 +
font-family:"Calibri","sans-serif";}
 +
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
 +
{margin-top:0cm;
 +
margin-right:0cm;
 +
margin-bottom:0cm;
 +
margin-left:36.0pt;
 +
margin-bottom:.0001pt;
 +
line-height:115%;
 +
font-size:11.0pt;
 +
font-family:"Calibri","sans-serif";}
 +
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
 +
{margin-top:0cm;
 +
margin-right:0cm;
 +
margin-bottom:0cm;
 +
margin-left:36.0pt;
 +
margin-bottom:.0001pt;
 +
line-height:115%;
 +
font-size:11.0pt;
 +
font-family:"Calibri","sans-serif";}
 +
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
 +
{margin-top:0cm;
 +
margin-right:0cm;
 +
margin-bottom:10.0pt;
 +
margin-left:36.0pt;
 +
line-height:115%;
 +
font-size:11.0pt;
 +
font-family:"Calibri","sans-serif";}
 +
span.Heading1Char
 +
{mso-style-name:"Heading 1 Char";
 +
mso-style-link:"Heading 1";
 +
font-family:"Cambria","serif";
 +
color:red;
 +
font-weight:bold;}
 +
.MsoChpDefault
 +
{font-family:"Calibri","sans-serif";}
 +
.MsoPapDefault
 +
{margin-bottom:10.0pt;
 +
line-height:115%;}
 +
@page WordSection1
 +
{size:612.0pt 792.0pt;
 +
margin:70.85pt 70.85pt 2.0cm 70.85pt;}
 +
div.WordSection1
 +
{page:WordSection1;}
 +
-->
 +
  </style>
 +
</head>
 +
<body lang="EN-US">
 +
<div class="WordSection1">
 +
<p class="MsoNormal" style="text-align: justify;"><span
 +
style="font-size: 10pt; line-height: 115%;">Producing
 +
recombinant virus particles for therapeutical
 +
applications is, besides specific cell targeting, purification and
 +
quantification assays of AAV-2, one intention of the Virus Construction
 +
Kit
 +
provided by the iGEM team Freiburg_Bioware 2010. For obtaining a
 +
modular
 +
toolkit, the complex biological system of the Adeno-associated virus
 +
serotype 2
 +
was examined by an exhaustive literature search. Subsequently, the
 +
essential
 +
components for AAV-2 particle production were extracted and redesigned
 +
to match
 +
the iGEM standard.</span></p>
 +
<p class="MsoNormal" style="text-align: justify;"><span
 +
style="font-size: 10pt; line-height: 115%;">The provided
 +
tripartite system is independent of a
 +
superinfection&nbsp; of Adeno- or herpes simplex viruses since the
 +
genes encoding
 +
the required helper-proteins are co-transfected. Inside the eukaryotic
 +
host
 +
cell, the DNA sequence containing the inverted terminal repeats (ITRs)
 +
is
 +
extracted and later encapsidated into the preformed capsids after
 +
production of
 +
single-stranded DNA. Consequently, this plasmid is known as the vector
 +
plasmid
 +
(pGOI). Promoter, <i>beta-globin</i> intron and the hGH
 +
terminator signal are
 +
flanked by the ITRs (ITRs, BBa_K404100 and BBa_K404101) and regulate
 +
transgene
 +
expression. The vector plasmid containing the desired gene of interest
 +
is
 +
cotransfected with the RepCap plasmid (BBa_K404001, BBa_K404002 or
 +
BBa_K404003)
 +
and the pHelper plasmid. To obtain the fully assembled vector plasmid,
 +
several
 +
assembly steps have to be performed.&nbsp; </span></p>
 +
<p class="MsoNormal" style="text-align: justify;"><span
 +
style="font-size: 10pt; line-height: 115%;">The Composite
 +
part </span><span style="font-size: 10pt; line-height: 115%;">[AAV2]-left-ITR_pCMV_betaglobin_CFP_hGH_[AAV2]-right-ITR
 +
provided by the iGEM team Freiburg_Bioware comprises all <i>cis</i>-elements
 +
required for efficient transgene expression in mammalian cells
 +
(polyadenylation
 +
terminator: </span><span
 +
style="font-size: 10pt; line-height: 115%;">BBa_K404108 </span><span
 +
style="font-size: 10pt; line-height: 115%;">and
 +
transcription enhancer element: </span><span
 +
style="font-size: 10pt; line-height: 115%;">BBa_K404107)</span><span
 +
style="font-size: 10pt; line-height: 115%;"> and
 +
encapsidation into virus
 +
particles (</span><span
 +
style="font-size: 10pt; line-height: 115%;">ITRs:
 +
BBa_K404100 and BBa_K404101). The CFP coding sequence as gene of
 +
interest enables
 +
facile detection of transduced cells using flow cytometry or
 +
fluorescence
 +
microscopy.</span></p>
 +
<p class="MsoNormal">&nbsp;</p>
 +
</div>
 +
</body>
 +
</html>
  
[[Image:Freiburg10_Vectorplasmid composite 2.png|thumb|center|480px]]<br>
 
  
  

Latest revision as of 12:44, 31 October 2010

[AAV2]-left-ITR_pCMV_betaglobin_CFP_hGH_[AAV2]-right-ITR


[AAV2-left-ITR_pCMV_betaglobin_CFP_hGH_[AAV2]-right-ITR ]
Freiburg10 Vectorplasmid composite 2.png
BioBrick Nr. BBa_K404120
RFC standard RFC 10
Requirement pSB1C3
Source pAAV_MCS provided by Stratagene
Submitted by [http://2010.igem.org/Team:Freiburg_Bioware FreiGEM 2010]


Freiburg10 Vectorplasmid composite 2.png

















Producing recombinant virus particles for therapeutical applications is, besides specific cell targeting, purification and quantification assays of AAV-2, one intention of the Virus Construction Kit provided by the iGEM team Freiburg_Bioware 2010. For obtaining a modular toolkit, the complex biological system of the Adeno-associated virus serotype 2 was examined by an exhaustive literature search. Subsequently, the essential components for AAV-2 particle production were extracted and redesigned to match the iGEM standard.

The provided tripartite system is independent of a superinfection  of Adeno- or herpes simplex viruses since the genes encoding the required helper-proteins are co-transfected. Inside the eukaryotic host cell, the DNA sequence containing the inverted terminal repeats (ITRs) is extracted and later encapsidated into the preformed capsids after production of single-stranded DNA. Consequently, this plasmid is known as the vector plasmid (pGOI). Promoter, beta-globin intron and the hGH terminator signal are flanked by the ITRs (ITRs, BBa_K404100 and BBa_K404101) and regulate transgene expression. The vector plasmid containing the desired gene of interest is cotransfected with the RepCap plasmid (BBa_K404001, BBa_K404002 or BBa_K404003) and the pHelper plasmid. To obtain the fully assembled vector plasmid, several assembly steps have to be performed. 

The Composite part [AAV2]-left-ITR_pCMV_betaglobin_CFP_hGH_[AAV2]-right-ITR provided by the iGEM team Freiburg_Bioware comprises all cis-elements required for efficient transgene expression in mammalian cells (polyadenylation terminator: BBa_K404108 and transcription enhancer element: BBa_K404107) and encapsidation into virus particles (ITRs: BBa_K404100 and BBa_K404101). The CFP coding sequence as gene of interest enables facile detection of transduced cells using flow cytometry or fluorescence microscopy.

 


Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal NgoMIV site found at 1319
    Illegal AgeI site found at 2039
  • 1000
    INCOMPATIBLE WITH RFC[1000]
    Illegal BsaI site found at 2441